CA125/MUC16-targeting antibody-drug conjugate (Genentech)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameCA125/MUC16-targeting antibody-drug conjugate (Genentech)

Drug Alias Name11D10.1.14-auristatin conjugates (Genentech)3A5 antibody-drug conjuagte (Genentech)1D10 antibody-drug conjugate (Genentech)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionMucin-16 inhibitors

TargetsMucin-16

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGenentech Inc

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A